HANSEN-TECHNOLOGIES
25.4.2024 12:01:33 CEST | Business Wire | Press release
Hansen Technologies (ASX:HSN), a leading global provider of software and services to the energy, water, and communications industries, is pleased to announce that Stockholm Exergi, a major energy provider in Sweden, is the latest to join the growing community of Hansen Trade users. Enabled by Hansen Trade, Stockholm Exergi will commence operations in a balance responsible party role and leverage the platform to process all trading operations in physical power markets, including Day-Ahead, Intraday, and Ancillary Services market trading.
Hansen Trade enables Stockholm Exergi to participate in all marketplaces with an automated trading tool, with a modern, cloud-native, and modular design. For Day-Ahead trading, the solution delivers a streamlined bidding process, detailed trade-result handling, and comprehensive safety features, making it possible to optimise all assets in the marketplace without spending time on manual processing. The fully automated Intraday Trading capability handles balance management and available capacity optimisation for all assets, round-the-clock, with highly flexible and dynamic trading strategy tools. Furthermore, the Ancillary Services capability optimises capacity in the aFRR, mFRR, and FCR markets.
Erik Forsén, Product Owner for Ancillary Services at Stockholm Exergi, commented: “To be truly effective when trading in physical marketplaces requires modern, automated trading tools. Our decision to begin operating as a balance-responsible party reinforced the need for a platform to optimise our asset fleet’s trading in multiple marketplaces. Tailored tools for bid handling and market communication convinced us that Hansen Trade was the right market solution to meet our evolving needs. Hansen also has a deep knowledge of the electricity markets and offers valuable advice on everything from strategy to operations. With Hansen Trade, we can start trading operations seamlessly and ensure that we unlock the total value potential of all our assets.”
David Castree, Chief Customer Officer at Hansen, commented: “It is clear that Stockholm Exergi are visionaries in the sector. Their transition from a conventional city-based energy provider to an active power trader, their participation in COP27, plus the announced creation – supported by the European Innovation Fund – of a carbon-capture and storage facility prove that. As such, their choice of Hansen Trade as the strategic power trading platform is all the more consequential and a genuine endorsement of Hansen’s leadership Hansen in this important space. Hansen’s power trading platform empowers several energy companies across the Nordic region, with Skelleftea Kraft, Bixia, Vantaa Energy, Tampereen Sähkölaitos, Malarenergi and Jämtkraft, to name a few. Leveraging Hansen Trade, these organisations operate with unparalleled agility in a highly dynamic market.”
Part of the Hansen Suite for Energy & Utilities, and delivered as a cloud-based SaaS solution, Hansen Trade fully meets the flexibility and scalability demands of the evolving energy trading market.
For further information about Hansen Technologies, please visit www.hansencx.com.
About Hansen
Hansen Technologies (ASX: HSN) is a leading global provider of software and services to the energy, water, and communications industries. With its award-winning software portfolio, Hansen serves customers in over 80 countries, helping them create, sell, and deliver new products and services, manage and analyse customer data, and control critical revenue management and customer support processes.
For more information, visit www.hansencx.com
Stockholm Exergi
Stockholm Exergi is Stockholm’s energy provider. Using resource-efficient solutions, Stockholm Exergi ensures that the growing Stockholm region has access to electricity, heating, cooling, and waste services. The company provides heat to more than 800,000 residents, and its 3,000-kilometre-long district heating network forms the basis for the societal benefits that Stockholm Exergi creates with its customers and partners.
For more information, visit https://www.stockholmexergi.se/en/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240425659483/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Egon Zehnder Names Ayşe Güçlü Onur Global Human Resources Practice Leader2.9.2026 15:00:00 CEST | Press release
Egon Zehnder has appointed Ayşe Güçlü Onur as Global Leader of its Human Resources Practice. This appointment comes as companies and boards increasingly look to CHROs to help shape business strategy, lead transformation, build leadership pipelines, and navigate major shifts in culture and the workforce. "CHROs used to be evaluated by how well they supported the business. Today, the best drive it," said Onur. "Our role is to help CHROs move from a seat at the table to a hand in business growth. We help them connect leadership decisions, talent, and culture directly to elevated performance. That's the shift Egon Zehnder is built to guide with our leadership advisory services." Egon Zehnder’s Human Resources Practice partners with companies to discover, develop, and transform future-ready CHROs, helping them shape the future of the function. This includes executive search, leadership assessment and development, board effectiveness, culture, succession planning, organizational transformati
Safe Software to Increase Global Headcount by Over 15% as Demand for AI-Ready Data Grows2.9.2026 15:00:00 CEST | Press release
The FME creator is recruiting for more than 60 roles across the UK, US and Canada before the end of December, less than a year after crossing $100M in revenue Safe Software, the creator of FME, the only All-Data, Any-AI enterprise integration platform with true support for spatial data, today announced it is recruiting for more than 60 roles throughout the remainder of 2026. The hiring will take the company past 400 employees, increasing headcount by over 15%, with new positions across the United Kingdom, the United States and Canada. The expansion follows a year in which Safe crossed $100 million in annual revenue, growing close to 20 percent year over year and moving ahead of schedule on its target of $250 million by 2028. The company also grew its employee base by over 20% in the same period. "The incredible growth that we’ve seen over the last 30+ years at Safe has always been a testament to the great people behind what we do," said Don Murray, Co-Founder and CEO of Safe Software.
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Datato Boehringer Ingelheim2.9.2026 14:00:00 CEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 14:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
Croma-Pharma Introduces Electronic Instructions for Use Across the saypha® Portfolio2.9.2026 13:37:00 CEST | Press release
Healthcare professionals in eligible markets can now access the Instructions for Use for the saypha® portfolio digitally by scanning a QR code on the product packaging Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructio
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
